Global Liver Biopsy System Market

Liver Biopsy System Comprehensive Study by Type (Needles, Guidance Systems, Biopsy kits and Reagents, Others), End User (Hospitals & Clinics, Diagnostic Centers, Others), Procedure (Percutaneous, Transjugular, Laparoscopic, Transgastric) Players and Region - Global Market Outlook to 2030

Liver Biopsy System Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Liver Biopsy System
Liver biopsy is an essential procedure in the diagnosis and treatment of liver diseases. It helps doctors to assess the health of the liver. Also, it is important for many reasons, such as ruling out any coexisting liver disease, staging and grading the severity of liver disease, treatment decisions, patient and provider reassurance, and as a standard for gauging future disease progression. The global liver biopsy system market is projected to witness a significant growth owing to increase in awareness among people about treatment and increased prevalence of liver diseases across the globe.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Companies are implementing various strategies such as mergers & acquisitions, new product development, joint ventures, partnerships and others. Medical technology and healthcare companies are setting standards by manufacturing liver biopsy devices with the help of various technological advancements Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Liver Biopsy System market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Argon Medical Devices, Inc. (United States), Becton Dickinson (United States), Boston Scientific Corporation (United States), Cook Medical (United States), RI.MOS. (Italy), Sterylab (Italy), Veran medical (United States), Medtronic (Ireland), INRAD Inc. (United States) and Kimal Plc (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Adroit Manufacturing Co. (India), Moller Medical (Germany) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Liver Biopsy System market by Type (Needles, Guidance Systems, Biopsy kits and Reagents and Others) and Region. On the basis of Type, Needles are dominating the market in the year 2023 where as Biopsy kits and Reagents stood as second largest market share.



On the basis of geography, the market of Liver Biopsy System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Asia Pacific, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by End User , the sub-segment i.e. Hospitals & Clinics will boost the Liver Biopsy System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Procedure, the sub-segment i.e. Percutaneous will boost the Liver Biopsy System market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Less risk of bleeding complications and less painful approaches

Market Growth Drivers:
Increase in awareness among people about treatment and Increased prevalence of liver diseases across the globe

Challenges:
Complications related to liver biopsy

Restraints:
High cost of diagnostic devices and instruments

Opportunities:
Growing demand for new techniques for diagnosis of chronic and the need for better diagnostic

Market Leaders and their expansionary development strategies
In January 2023, BD, a leading global medical technology company, introduced a new, robotic track system for the BD Kiestra microbiology laboratory solution that automates lab specimen processing, which may help to reduce manual labor and wait time for results.
In August 2022, London-based startup Metadeq has developed a noninvasive blood test with the goal of bypassing the need for liver biopsies when diagnosing the severity of liver disease.


Key Target Audience
Manufacturers of Liver Biopsy Equipments, Suppliers of Liver Biopsy Equipment Parts, Governmental Bodies, Research and Development (R&D) Companies, Academic Institutes and Universities, Medical Device Manufacturers, Medical Device Suppliers and Market Research and Consulting Firms

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Needles
  • Guidance Systems
  • Biopsy kits and Reagents
  • Others
By End User
  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

By Procedure
  • Percutaneous
  • Transjugular
  • Laparoscopic
  • Transgastric

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in awareness among people about treatment
      • 3.2.2. Increased prevalence of liver diseases across the globe
    • 3.3. Market Challenges
      • 3.3.1. Complications related to liver biopsy
    • 3.4. Market Trends
      • 3.4.1. Less risk of bleeding complications and less painful approaches
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Liver Biopsy System, by Type, End User , Procedure and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Liver Biopsy System (Volume)
      • 5.2.1. Global Liver Biopsy System by: Type (Volume)
        • 5.2.1.1. Needles
        • 5.2.1.2. Guidance Systems
        • 5.2.1.3. Biopsy kits and Reagents
        • 5.2.1.4. Others
      • 5.2.2. Global Liver Biopsy System by: Procedure (Volume)
        • 5.2.2.1. Percutaneous
        • 5.2.2.2. Transjugular
        • 5.2.2.3. Laparoscopic
        • 5.2.2.4. Transgastric
      • 5.2.3. Global Liver Biopsy System Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Liver Biopsy System (Price)
      • 5.3.1. Global Liver Biopsy System by: Type (Price)
  • 6. Liver Biopsy System: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Argon Medical Devices, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton Dickinson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boston Scientific Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cook Medical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. RI.MOS. (Italy)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sterylab (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Veran medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medtronic (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. INRAD Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kimal Plc (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Liver Biopsy System Sale, by Type, End User , Procedure and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Liver Biopsy System (Volume)
      • 7.2.1. Global Liver Biopsy System by: Type (Volume)
        • 7.2.1.1. Needles
        • 7.2.1.2. Guidance Systems
        • 7.2.1.3. Biopsy kits and Reagents
        • 7.2.1.4. Others
      • 7.2.2. Global Liver Biopsy System by: Procedure (Volume)
        • 7.2.2.1. Percutaneous
        • 7.2.2.2. Transjugular
        • 7.2.2.3. Laparoscopic
        • 7.2.2.4. Transgastric
      • 7.2.3. Global Liver Biopsy System Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Liver Biopsy System (Price)
      • 7.3.1. Global Liver Biopsy System by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Liver Biopsy System Sales: by Type(K Units)
  • Table 2. Liver Biopsy System Sales Needles , by Region K Units (2018-2023)
  • Table 3. Liver Biopsy System Sales Guidance Systems , by Region K Units (2018-2023)
  • Table 4. Liver Biopsy System Sales Biopsy kits and Reagents , by Region K Units (2018-2023)
  • Table 5. Liver Biopsy System Sales Others , by Region K Units (2018-2023)
  • Table 6. Liver Biopsy System Sales: by Procedure(K Units)
  • Table 7. Liver Biopsy System Sales Percutaneous , by Region K Units (2018-2023)
  • Table 8. Liver Biopsy System Sales Transjugular , by Region K Units (2018-2023)
  • Table 9. Liver Biopsy System Sales Laparoscopic , by Region K Units (2018-2023)
  • Table 10. Liver Biopsy System Sales Transgastric , by Region K Units (2018-2023)
  • Table 11. South America Liver Biopsy System Sales, by Country K Units (2018-2023)
  • Table 12. South America Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 13. South America Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 14. South America Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 15. Brazil Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 16. Brazil Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 17. Brazil Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 18. Argentina Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 19. Argentina Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 20. Argentina Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 21. Rest of South America Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 22. Rest of South America Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 23. Rest of South America Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 24. Asia Pacific Liver Biopsy System Sales, by Country K Units (2018-2023)
  • Table 25. Asia Pacific Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 26. Asia Pacific Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 27. Asia Pacific Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 28. China Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 29. China Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 30. China Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 31. Japan Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 32. Japan Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 33. Japan Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 34. India Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 35. India Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 36. India Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 37. South Korea Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 38. South Korea Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 39. South Korea Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 40. Taiwan Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 41. Taiwan Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 42. Taiwan Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 43. Australia Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 44. Australia Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 45. Australia Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 46. Rest of Asia-Pacific Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 47. Rest of Asia-Pacific Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 48. Rest of Asia-Pacific Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 49. Europe Liver Biopsy System Sales, by Country K Units (2018-2023)
  • Table 50. Europe Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 51. Europe Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 52. Europe Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 53. Germany Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 54. Germany Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 55. Germany Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 56. France Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 57. France Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 58. France Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 59. Italy Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 60. Italy Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 61. Italy Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 62. United Kingdom Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 63. United Kingdom Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 64. United Kingdom Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 65. Netherlands Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 66. Netherlands Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 67. Netherlands Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 68. Rest of Europe Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 69. Rest of Europe Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 70. Rest of Europe Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 71. MEA Liver Biopsy System Sales, by Country K Units (2018-2023)
  • Table 72. MEA Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 73. MEA Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 74. MEA Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 75. Middle East Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 76. Middle East Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 77. Middle East Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 78. Africa Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 79. Africa Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 80. Africa Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 81. North America Liver Biopsy System Sales, by Country K Units (2018-2023)
  • Table 82. North America Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 83. North America Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 84. North America Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 85. United States Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 86. United States Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 87. United States Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 88. Canada Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 89. Canada Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 90. Canada Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 91. Mexico Liver Biopsy System Sales, by Type K Units (2018-2023)
  • Table 92. Mexico Liver Biopsy System Sales, by End User K Units (2018-2023)
  • Table 93. Mexico Liver Biopsy System Sales, by Procedure K Units (2018-2023)
  • Table 94. Liver Biopsy System: by Type(USD/Units)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Liver Biopsy System Sales: by Type(K Units)
  • Table 106. Liver Biopsy System Sales Needles , by Region K Units (2025-2030)
  • Table 107. Liver Biopsy System Sales Guidance Systems , by Region K Units (2025-2030)
  • Table 108. Liver Biopsy System Sales Biopsy kits and Reagents , by Region K Units (2025-2030)
  • Table 109. Liver Biopsy System Sales Others , by Region K Units (2025-2030)
  • Table 110. Liver Biopsy System Sales: by Procedure(K Units)
  • Table 111. Liver Biopsy System Sales Percutaneous , by Region K Units (2025-2030)
  • Table 112. Liver Biopsy System Sales Transjugular , by Region K Units (2025-2030)
  • Table 113. Liver Biopsy System Sales Laparoscopic , by Region K Units (2025-2030)
  • Table 114. Liver Biopsy System Sales Transgastric , by Region K Units (2025-2030)
  • Table 115. South America Liver Biopsy System Sales, by Country K Units (2025-2030)
  • Table 116. South America Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 117. South America Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 118. South America Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 119. Brazil Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 120. Brazil Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 121. Brazil Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 122. Argentina Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 123. Argentina Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 124. Argentina Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 125. Rest of South America Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 126. Rest of South America Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 127. Rest of South America Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 128. Asia Pacific Liver Biopsy System Sales, by Country K Units (2025-2030)
  • Table 129. Asia Pacific Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 130. Asia Pacific Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 131. Asia Pacific Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 132. China Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 133. China Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 134. China Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 135. Japan Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 136. Japan Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 137. Japan Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 138. India Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 139. India Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 140. India Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 141. South Korea Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 142. South Korea Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 143. South Korea Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 144. Taiwan Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 145. Taiwan Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 146. Taiwan Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 147. Australia Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 148. Australia Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 149. Australia Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 150. Rest of Asia-Pacific Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 151. Rest of Asia-Pacific Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 152. Rest of Asia-Pacific Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 153. Europe Liver Biopsy System Sales, by Country K Units (2025-2030)
  • Table 154. Europe Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 155. Europe Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 156. Europe Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 157. Germany Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 158. Germany Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 159. Germany Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 160. France Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 161. France Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 162. France Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 163. Italy Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 164. Italy Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 165. Italy Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 166. United Kingdom Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 167. United Kingdom Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 168. United Kingdom Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 169. Netherlands Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 170. Netherlands Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 171. Netherlands Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 172. Rest of Europe Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 173. Rest of Europe Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 174. Rest of Europe Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 175. MEA Liver Biopsy System Sales, by Country K Units (2025-2030)
  • Table 176. MEA Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 177. MEA Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 178. MEA Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 179. Middle East Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 180. Middle East Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 181. Middle East Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 182. Africa Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 183. Africa Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 184. Africa Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 185. North America Liver Biopsy System Sales, by Country K Units (2025-2030)
  • Table 186. North America Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 187. North America Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 188. North America Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 189. United States Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 190. United States Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 191. United States Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 192. Canada Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 193. Canada Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 194. Canada Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 195. Mexico Liver Biopsy System Sales, by Type K Units (2025-2030)
  • Table 196. Mexico Liver Biopsy System Sales, by End User K Units (2025-2030)
  • Table 197. Mexico Liver Biopsy System Sales, by Procedure K Units (2025-2030)
  • Table 198. Liver Biopsy System: by Type(USD/Units)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Liver Biopsy System: by Type K Units (2018-2023)
  • Figure 5. Global Liver Biopsy System: by Procedure K Units (2018-2023)
  • Figure 6. South America Liver Biopsy System Share (%), by Country
  • Figure 7. Asia Pacific Liver Biopsy System Share (%), by Country
  • Figure 8. Europe Liver Biopsy System Share (%), by Country
  • Figure 9. MEA Liver Biopsy System Share (%), by Country
  • Figure 10. North America Liver Biopsy System Share (%), by Country
  • Figure 11. Global Liver Biopsy System: by Type USD/Units (2018-2023)
  • Figure 12. Global Liver Biopsy System share by Players 2023 (%)
  • Figure 13. Global Liver Biopsy System share by Players (Top 3) 2023(%)
  • Figure 14. Global Liver Biopsy System share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Argon Medical Devices, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Argon Medical Devices, Inc. (United States) Revenue: by Geography 2023
  • Figure 18. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton Dickinson (United States) Revenue: by Geography 2023
  • Figure 20. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 22. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 23. Cook Medical (United States) Revenue: by Geography 2023
  • Figure 24. RI.MOS. (Italy) Revenue, Net Income and Gross profit
  • Figure 25. RI.MOS. (Italy) Revenue: by Geography 2023
  • Figure 26. Sterylab (Italy) Revenue, Net Income and Gross profit
  • Figure 27. Sterylab (Italy) Revenue: by Geography 2023
  • Figure 28. Veran medical (United States) Revenue, Net Income and Gross profit
  • Figure 29. Veran medical (United States) Revenue: by Geography 2023
  • Figure 30. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 31. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 32. INRAD Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. INRAD Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Kimal Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Kimal Plc (United Kingdom) Revenue: by Geography 2023
  • Figure 36. Global Liver Biopsy System: by Type K Units (2025-2030)
  • Figure 37. Global Liver Biopsy System: by Procedure K Units (2025-2030)
  • Figure 38. South America Liver Biopsy System Share (%), by Country
  • Figure 39. Asia Pacific Liver Biopsy System Share (%), by Country
  • Figure 40. Europe Liver Biopsy System Share (%), by Country
  • Figure 41. MEA Liver Biopsy System Share (%), by Country
  • Figure 42. North America Liver Biopsy System Share (%), by Country
  • Figure 43. Global Liver Biopsy System: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Argon Medical Devices, Inc. (United States)
  • Becton Dickinson (United States)
  • Boston Scientific Corporation (United States)
  • Cook Medical (United States)
  • RI.MOS. (Italy)
  • Sterylab (Italy)
  • Veran medical (United States)
  • Medtronic (Ireland)
  • INRAD Inc. (United States)
  • Kimal Plc (United Kingdom)
Additional players considered in the study are as follows:
Adroit Manufacturing Co. (India) , Moller Medical (Germany) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 233 Pages 56 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Liver Biopsy System Market Quantitative research analysis
Global Liver Biopsy System Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Argon Medical Devices, Inc. (United States), Becton Dickinson (United States), Boston Scientific Corporation (United States), Cook Medical (United States), RI.MOS. (Italy), Sterylab (Italy), Veran medical (United States), Medtronic (Ireland), INRAD Inc. (United States) and Kimal Plc (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Less risk of bleeding complications and less painful approaches" is seen as one of major influencing trends for Liver Biopsy System Market during projected period 2023-2030.
The Liver Biopsy System market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Liver Biopsy System Market Report?

Have a Query? Click Here

Other Related Reports

Pedicle Screw Systems Comprehensive Study by Type (Conical Pedicle Screw, Cylindrical  Pedicle Screw, Dual Cored Pedicle Screw), Application (Hospitals, Clinics, Others), Indication (Spinal Deformiti...
$ 3450
Pharmaceutical Equipment Comprehensive Study by Type (API Equipment, Preparation Machinery, Medicinal Crushing Machine, Herbal Medicine Processing Machinery, Pharmaceutical Water Equipment, Pharmaceu...
$ 3650
EEG Headset Comprehensive Study by Type (Battery, Charge), Application (Hospital, Pharmacy), Distribution Channel (Ecommerce, Wholesalers and Retailers), Size (Child Head Sizes, Adult Head Sizes), De...
$ 3450
ECG Telemeters Comprehensive Study by Type (Digital ECG Telemeters, Analog ECG Telemeters), Technology (Resting ECG Systems, Holter Monitoring, Stress ECG Systems, Event Monitoring, Mobile Cardiac Te...
$ 3450
CT Detector Comprehensive Study by Type (Single Detector, Multi-Detector), Application (Hospitals, Clnics, Research Institutions) Players and Region - Global Market Outlook to 2028
$ 3500
Ophthalmic Blades Comprehensive Study by Type (Diamond Knife, Laser Knife, Others), Application (Cataract, Glaucoma, Endothelial Keratoplasty, Others), Usage (Reusable, Disposable), End User (Hospita...
$ 3350